These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 33848152)

  • 1. Mechanistic Differences of Activation of Rac1
    Senyuz S; Jang H; Nussinov R; Keskin O; Gursoy A
    J Phys Chem B; 2021 Apr; 125(15):3790-3802. PubMed ID: 33848152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RAC1P29S is a spontaneously activating cancer-associated GTPase.
    Davis MJ; Ha BH; Holman EC; Halaban R; Schlessinger J; Boggon TJ
    Proc Natl Acad Sci U S A; 2013 Jan; 110(3):912-7. PubMed ID: 23284172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural and functional characterization of fast-cycling RhoF GTPase.
    Sugawara R; Ueda H; Honda R
    Biochem Biophys Res Commun; 2019 May; 513(2):522-527. PubMed ID: 30981505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of point mutation P29S in RAC1 on tumorigenesis.
    Rajendran V; Gopalakrishnan C; Purohit R
    Tumour Biol; 2016 Nov; 37(11):15293-15304. PubMed ID: 27699663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DOCK1 inhibition suppresses cancer cell invasion and macropinocytosis induced by self-activating Rac1
    Tomino T; Tajiri H; Tatsuguchi T; Shirai T; Oisaki K; Matsunaga S; Sanematsu F; Sakata D; Yoshizumi T; Maehara Y; Kanai M; Cote JF; Fukui Y; Uruno T
    Biochem Biophys Res Commun; 2018 Feb; 497(1):298-304. PubMed ID: 29432733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncogenic mutations on Rac1 affect global intrinsic dynamics underlying GTP and PAK1 binding.
    Acuner SE; Sumbul F; Torun H; Haliloglu T
    Biophys J; 2021 Mar; 120(5):866-876. PubMed ID: 33515600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The RAC1 P29S hotspot mutation in melanoma confers resistance to pharmacological inhibition of RAF.
    Watson IR; Li L; Cabeceiras PK; Mahdavi M; Gutschner T; Genovese G; Wang G; Fang Z; Tepper JM; Stemke-Hale K; Tsai KY; Davies MA; Mills GB; Chin L
    Cancer Res; 2014 Sep; 74(17):4845-4852. PubMed ID: 25056119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RAC1
    Lionarons DA; Hancock DC; Rana S; East P; Moore C; Murillo MM; Carvalho J; Spencer-Dene B; Herbert E; Stamp G; Damry D; Calado DP; Rosewell I; Fritsch R; Neubig RR; Molina-Arcas M; Downward J
    Cancer Cell; 2019 Jul; 36(1):68-83.e9. PubMed ID: 31257073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing the mechanism of fast-cycling cancer-associated mutations of Rac1 small Rho GTPase.
    Parise A; Magistrato A
    Protein Sci; 2024 Apr; 33(4):e4939. PubMed ID: 38501467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RAC1mutation is not a predictive biomarker for PI3'-kinase-β-selective pathway-targeted therapy.
    Foth M; Parkman G; Battistone B; McMahon M
    Pigment Cell Melanoma Res; 2020 Sep; 33(5):719-730. PubMed ID: 32406574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conformational landscape alternations promote oncogenic activities of Ras-related C3 botulinum toxin substrate 1 as revealed by NMR.
    Toyama Y; Kontani K; Katada T; Shimada I
    Sci Adv; 2019 Mar; 5(3):eaav8945. PubMed ID: 30891502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Active and Inactive Cdc42 Differ in Their Insert Region Conformational Dynamics.
    Haspel N; Jang H; Nussinov R
    Biophys J; 2021 Jan; 120(2):306-318. PubMed ID: 33347888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming mutations of RAC guanosine triphosphatases in human cancers.
    Kawazu M; Ueno T; Kontani K; Ogita Y; Ando M; Fukumura K; Yamato A; Soda M; Takeuchi K; Miki Y; Yamaguchi H; Yasuda T; Naoe T; Yamashita Y; Katada T; Choi YL; Mano H
    Proc Natl Acad Sci U S A; 2013 Feb; 110(8):3029-34. PubMed ID: 23382236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unique vulnerability of RAC1-mutant melanoma to combined inhibition of CDK9 and immune checkpoints.
    Cannon AC; Budagyan K; Uribe-Alvarez C; Kurimchak AM; Araiza-Olivera D; Cai KQ; Peri S; Zhou Y; Duncan JS; Chernoff J
    Oncogene; 2024 Mar; 43(10):729-743. PubMed ID: 38243078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RAC1 and melanoma.
    Halaban R
    Clin Ther; 2015 Mar; 37(3):682-5. PubMed ID: 25465943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystal structure of the Rac1-RhoGDI complex involved in nadph oxidase activation.
    Grizot S; Fauré J; Fieschi F; Vignais PV; Dagher MC; Pebay-Peyroula E
    Biochemistry; 2001 Aug; 40(34):10007-13. PubMed ID: 11513578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular dynamic simulation reveals the inhibiting impact of Rhein on wild-type and P29S-mutated Rac1.
    Etebar N; Hamidi SH; Naderpour S; Abouali O; Hamidi SH; Hajipour-Verdom B; Zali A; Alipour M; Rahimzadegan M
    Front Mol Biosci; 2024; 11():1414197. PubMed ID: 39161777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RAC1 P29S regulates PD-L1 expression in melanoma.
    Vu HL; Rosenbaum S; Purwin TJ; Davies MA; Aplin AE
    Pigment Cell Melanoma Res; 2015 Sep; 28(5):590-8. PubMed ID: 26176707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced Dendritic Actin Network Formation in Extended Lamellipodia Drives Proliferation in Growth-Challenged Rac1
    Mohan AS; Dean KM; Isogai T; Kasitinon SY; Murali VS; Roudot P; Groisman A; Reed DK; Welf ES; Han SJ; Noh J; Danuser G
    Dev Cell; 2019 May; 49(3):444-460.e9. PubMed ID: 31063759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification and biochemical properties of Rac1, 2, 3 and the splice variant Rac1b.
    Haeusler LC; Hemsath L; Fiegen D; Blumenstein L; Herbrand U; Stege P; Dvorsky R; Ahmadian MR
    Methods Enzymol; 2006; 406():1-11. PubMed ID: 16472645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.